Statistics Applied to Clinical Trials: Self-Assessment BookSpringer Science & Business Media, 31. sij 2003. - Broj stranica: 226 The authors have taught statistics and given statistics workshops in France and the Netherlands for almost 4 years by now. Their material, mainly on power point, consists of 12 lectures that have been continuously changed and improved by interaction with various audiences. For the purpose of the current book simple English text has been added to the formulas and figures, and the power points sheets have been rewritten in the format given by Kluwer Academic Publishers. Cartoons have been removed, since this is not so relevant for the transmission of thought through a written text, and at the end of each lecture (chapter) a representative number of questions and exercises for self-assessment have been added. At the end of the book detailed answers to the questions and exercises per lecture are given. The book has been produced with the same size and frontpage as the textbook "Statistics Applied To Clinical Trials" by the same authors and edited by same publishers ( 2nd Edition, DordrechtiBostonlLondon, 2002), and can be applied together with the current self-assessment book or separately. The current self-assessment book is different from the texbook, because it focuses on the most important aspects rather than trying to be complete. So, it does not deal with all of the subjects assessed in the texbook. Instead, it repeats on and on the principle things that are needed for every analysis, and it gives many examples that are further explained by arrows in the figures. |
Sadržaj
III | 1 |
VII | 2 |
X | 3 |
XI | 4 |
XII | 5 |
XIII | 6 |
XIV | 7 |
XV | 8 |
CXV | 88 |
CXIX | 89 |
CXX | 90 |
CXXI | 91 |
CXXIII | 92 |
CXXIV | 93 |
CXXV | 94 |
CXXVI | 95 |
XVII | 10 |
XVIII | 12 |
XIX | 14 |
XXI | 15 |
XXIV | 16 |
XXV | 17 |
XXVI | 18 |
XXVII | 19 |
XXVIII | 22 |
XXXIII | 23 |
XXXVI | 25 |
XXXVII | 26 |
XXXVIII | 27 |
XXXIX | 28 |
XLI | 29 |
XLIII | 30 |
XLV | 31 |
XLIX | 32 |
L | 33 |
LII | 38 |
LV | 39 |
LVI | 40 |
LVIII | 41 |
LX | 42 |
LXI | 43 |
LXII | 44 |
LXIV | 45 |
LXVI | 46 |
LXVII | 47 |
LXIX | 48 |
LXXI | 50 |
LXXII | 51 |
LXXIII | 52 |
LXXIV | 53 |
LXXV | 54 |
LXXVI | 55 |
LXXVII | 56 |
LXXIX | 57 |
LXXXI | 58 |
LXXXIII | 59 |
LXXXIV | 60 |
LXXXV | 61 |
LXXXVI | 62 |
LXXXVII | 63 |
LXXXIX | 64 |
XC | 65 |
XCI | 68 |
XCIII | 69 |
XCV | 70 |
XCVII | 71 |
XCIX | 73 |
CI | 74 |
CII | 75 |
CV | 76 |
CVII | 77 |
CX | 78 |
CXI | 80 |
CXII | 81 |
CXIII | 82 |
CXIV | 86 |
CXXVIII | 96 |
CXXIX | 98 |
CXXXII | 99 |
CXXXIII | 100 |
CXXXIV | 101 |
CXXXVI | 102 |
CXXXVII | 103 |
CXXXVIII | 104 |
CXLI | 105 |
CXLIII | 106 |
CXLV | 107 |
CXLVII | 108 |
CXLIX | 109 |
CLI | 112 |
CLIII | 113 |
CLV | 114 |
CLVI | 115 |
CLVII | 116 |
CLX | 117 |
CLXI | 118 |
CLXIII | 119 |
CLXV | 124 |
CLXVIII | 125 |
CLXIX | 126 |
CLXX | 127 |
CLXXI | 128 |
CLXXII | 129 |
CLXXIII | 130 |
CLXXIV | 131 |
CLXXV | 132 |
CLXXVI | 133 |
CLXXVII | 134 |
CLXXIX | 135 |
CLXXXI | 136 |
CLXXXII | 137 |
CLXXXV | 138 |
CLXXXVI | 140 |
CLXXXIX | 141 |
CXCI | 142 |
CXCII | 143 |
CXCIV | 144 |
CXCV | 145 |
CXCVIII | 147 |
CXCIX | 149 |
CCIV | 150 |
CCVI | 151 |
CCVII | 154 |
CCIX | 155 |
CCXIII | 156 |
CCXV | 157 |
CCXVII | 162 |
CCXXIII | 163 |
CCXXVI | 164 |
CCXXVII | 165 |
CCXXIX | 167 |
CCXXX | 168 |
CCXXXI | 176 |
CCXXXII | 186 |
Ostala izdanja - Prikaži sve
Statistics Applied to Clinical Trials: Self-Assessment Book Ton J. Cleophas,A.H. Zwinderman,A.F. Cleophas Ograničeni pregled - 2012 |
Uobičajeni izrazi i fraze
ACE-inhibitor alpha alternative is correct ANOVA assessed AUC left AUC right B₁ B₂ baseline beta Bonferroni calculated censored data chance of finding CHAPTER Chi-square distribution chi-squared test clinical trials compared confidence interval continuous data correlation covariate degrees of freedom discrete drug effect efficacy equivalence testing estimate EXAMPLE graph hazard heterogeneity hypertension independent interim analysis linear regression logrank test McNemar's test mean result meta-analyses method mmol/L multiple comparisons multiple testing negative normal distribution null null-hypothesis number of patients observed odds ratio p-value paired placebo pooled Pravastatin prior hypothesis procedure proportional data protocol publication bias quantitative rank numbers rejected residual scientific SEMS distant side-effects significance level significantly different Sleepiness standard error statin statistical analysis statistical power strict inclusion criteria T-Table t-test time-point treatment groups trials similar type-I error rate unpaired variable variance variation x-axis X₁ zero